GeoVax Labs (GOVX) Asset Utilization Ratio (2011 - 2026)
GeoVax Labs (GOVX) posted quarterly Asset Utilization Ratio of 0.16 for Q2 2026, down 79.56% year-over-year from 0.76 in Q2 2025, and down 59.25% quarter-over-quarter from 0.38 in Q4 2025.
GeoVax Labs (GOVX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Asset Utilization Ratio for 15 consecutive years, with 0.16 the latest figure, recorded in Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 79.56% year-over-year to 0.16; the TTM figure through Jun 2026 stood at 0.16 (down 79.56% YoY), while the FY2025 annual figure was 0.34, down 24.29% from the prior year.
- Asset Utilization Ratio eased to 0.16 in Q2 2026 per GOVX's latest filing, from 0.38 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.76 in Q2 2025 and bottomed at 0.0 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 0.28 across 4 years, with a median of 0.27 in 2025.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 90.88% — and 2025, when it jumped 840.91%.
- GeoVax Labs' Asset Utilization Ratio stood at 0.0 in 2022, then soared by 17501.93% to 0.41 in 2024, then slipped by 7.23% to 0.38 in 2025, then tumbled by 59.25% to 0.16 in 2026.
- Business Quant data shows GOVX's Asset Utilization Ratio at 0.16 in Q2 2026, 0.38 in Q4 2025, and 0.56 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | 0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.16 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.56 |
| Jun 30, 2025 | 0.76 |
| Mar 31, 2025 | 0.59 |
| Dec 31, 2024 | 0.41 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | 0.08 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.04 |
| Mar 31, 2021 | 0.08 |
| Dec 31, 2020 | 0.16 |
| Sep 30, 2020 | 0.29 |
| Jun 30, 2020 | 1.97 |
| Mar 31, 2020 | 2.35 |